Sign inJoin waitlistJoin the waitlist

Joanne Weidhaas

Vice Chair, Division of Molecular and Cellular Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · · · · ·

History

Division of Molecular and Cellular Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center
Present
UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Memorial Sloan Kettering Cancer Center
2000–2004
Radiation Oncology
Memorial Sloan Kettering Cancer Center
2000–2004
Steward Carney Hospital Inc.
1999–2000
MSM, Stanford Graduate School of Business, 2013
Tufts University School of Medicine
1995–1999
Yale University
1991–1995

Research

Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Journal of Clinical Oncology · 2006 · 883 citations
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
Molecular Therapy · 2011 · 556 citations
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk
Cancer Research · 2008 · Last of 21 authors · 535 citations

Michael Steinberg
15 papers
Amar Kishan
11 papers
Elena Ratner
7 papers · 6 as a fellow
Luca Valle
7 papers · 2 as a resident
Adam Dicker
6 papers
David Gaffney
5 papers
LH
Lyndsay Harris
5 papers
Susan Higgins
5 papers
Anuja Jhingran
4 papers
Daniel Spratt
4 papers
DT
David Tuck
4 papers
Maggie DiNome
4 papers

Grants

Germ-Line miRNA Binding Site Variants as Biomarkers of Toxicity and Response to Checkpoint Inhibition
National Cancer Institute · R01
Contact PI · $1.8M · University of California Los Angeles
2019–2025
The UCLA Center for Medical Countermeasures Against Radiation
National Institute of Allergy and Infectious Diseases · U19
PI · $15.7M · University of California Los Angeles
2005–2021
MicroRNAs to Understand Cause and Outcome in Breast Cancer
National Cancer Institute · R01
Contact PI · $1.7M · University of California Los Angeles
2012–2017
Let-7 microRNAs in Lung Cancer: Altering Growth and Radioresistance
National Cancer Institute · R01
Contact PI · $1.7M · Yale University
2009–2014

Clinical trials

Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Principal investigator · Recruiting
Jonsson Comprehensive Cancer Center
2014–2027
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Principal investigator · Recruiting
MiraKind
2014–2035
Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma
Principal investigator · Completed
Yale University
2006–2013